ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2013
Privacy-by-Design: Understanding Data Access Models for Secondary Data.
Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Knocking on heaven's door: The gap between health institutions and academies in generating knowledge utilizing real-world data.Frontiers in public health · 2022Article
- US Privacy Laws Go Against Public Preferences and Impede Public Health and Research: Survey Study.Journal of medical Internet research · 2021Article
- Priorities to Overcome Barriers Impacting Data Science Application in Emergency Care Research.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2019Article
- A Position Statement on Population Data Science: The Science of Data about People.International journal of population data science · 2018Article
- Big data in medicine is driving big changes.Yearbook of medical informatics · 2014Review
- Privacy preserving interactive record linkage (PPIRL).Journal of the American Medical Informatics Association : JAMIAReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Today there is a constant flow of data into, out of, and between ever-larger and ever-more complex databases about people. Together, these digital traces collectively capture our social genome , the footprints of our society. The burgeoning field of population informatics is the systematic study of populations via secondary analysis of such massive data collections (termed "big data") about people. In particular, health informatics analyzes electronic health records to improve health outcomes for a population. Privacy protection in such secondary data analysis research is complex and requires a holistic approach which combines technology, statistics, policy and a shift in culture of information accountability through transparency rather than secrecy. We review state of the art in privacy protection technology and policy frameworks from widely different fields, and synthesize the findings to present a comprehensive system of privacy protection in population informatics research using the privacy-by-design approach. Based on common activities in the workflow, we describe the pros and cons of four different data access models - restricted access, controlled access, monitored access, and open access - that minimize risk and maximize usability of data. We then evaluate the system by analyzing the risk and usability of data through a realistic example. We conclude that deployed together the four data access models can provide a comprehensive system for privacy protection, balancing the risk and usability of secondary data in population informatics research.
Identifiers
24303251PMC3845756What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.